• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

How to Approach Severe AD With Combination Therapy

Author(s):

Matthew Zirwas, MD

A panelist discusses how combining different therapeutic approaches, such as topical agents with systemic medications, can provide optimal control for patients with severe atopic dermatitis while managing both acute flares and long-term disease maintenance.

Current Time 0:00
Duration 5:50
Loaded: 0%
Stream Type LIVE
Remaining Time 5:50
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Related Videos
    1 expert is featured in this series.
    Recapping the Evolving Treatment Landscape for Atopic Dermatitis
    1 expert in this video
    Sunscreen Ingredients for UV and Visible Light Protection
    1 expert in this video
    The Solar Spectrum and Impact on Skin Health
    1 expert in this video
    Discussing Efficacy and Safety of JAK Inhibitors With Patients and Caregivers
    1 expert in this video
    Patient Considerations for Selecting Treatment for a 16-Year-Old Male With Severe Alopecia Areata
    Future Directions for Pediatric Atopic Dermatitis Management and Research
    Future Directions for Pediatric Atopic Dermatitis Management and Research
    New Systemic Therapies for Pediatric Atopic Dermatitis: Nemolizumab and Oral JAK Inhibitors
    New Systemic Therapies for Pediatric Atopic Dermatitis: Nemolizumab and Oral JAK Inhibitors
    4 experts are featured in this series.
    The JAK-STAT Signaling Pathway and Its Role in Atopic Dermatitis
    4 experts are featured in this series.
    Selecting Systemic Therapy for Patients with Moderate to Severe Atopic Dermatitis
    Pipeline Updates on the Horizon From Arcutis Biotherapeutics
    Pipeline Updates on the Horizon From Arcutis Biotherapeutics
    Related Content
    New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
    March 13th 2025

    New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis

    The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
    August 2nd 2024

    The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

    Ruxolitinib Cream Shows Lasting Results in Pediatric Max-Use Trial
    March 12th 2025

    Ruxolitinib Cream Shows Lasting Results in Pediatric Max-Use Trial

    The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
    July 1st 2024

    The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

    Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025
    March 11th 2025

    Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025

    Addressing Disparities in Inflammatory Skin Diseases in Darker Skin Tones
    March 9th 2025

    Addressing Disparities in Inflammatory Skin Diseases in Darker Skin Tones

    © 2025 MJH Life Sciences

    All rights reserved.